ICI delisting ends bad month for US markets

Peter Madigan
01 Jun 2007

Tweet
Facebook
LinkedIn
Save this article
Send to
Print this page

NEW YORK - The role the Sarbanes-Oxley Act (Sox) is playing in driving firms away from public listings in the US has been thrown into the spotlight once again, after a bad month saw a wave of foreign firms flee the American capital markets.

British chemical company ICI announced on May 29 its intent to scrap its secondary exchange listing in the US, citing the cost of regulation as the key factor in its decision.

“It no longer makes sense from a cost and administrative perspective to submit

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact [email protected] or view our subscription options here: http://subscriptions.risk.net/subscribe

You are currently unable to print this content. Please contact [email protected] to find out more.

You are currently unable to copy this content. Please contact [email protected] to find out more.

You may share this content using our article tools. Printing this content is for the sole use of the Authorised User (named subscriber), as outlined in our terms and conditions - https://www.infopro-insight.com/terms-conditions/insight-subscriptions/

If you would like to purchase additional rights please email [email protected]

You may share this content using our article tools. Copying this content is for the sole use of the Authorised User (named subscriber), as outlined in our terms and conditions - https://www.infopro-insight.com/terms-conditions/insight-subscriptions/

If you would like to purchase additional rights please email [email protected]